Table 1.
The number of mother–child pairs reported in each analysed study by clinical outcome, presence of laboratory marker of congenital infection, and MIP status
|
PCR-confirmed, by trimester of infection |
PCR-negative, by trimester of infection |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | Not reported | 1 | 2 | 3 | Not reported | ||
| Pomar et al (2018)16 | |||||||||
| CZS | |||||||||
| LMCI present | 2 | 3 | 0 | .. | .. | .. | .. | .. | |
| LMCI absent | 0 | 0 | 0 | .. | .. | .. | .. | .. | |
| OPZRO | |||||||||
| LMCI present | 5 | 19 | 6 | .. | .. | .. | .. | .. | |
| LMCI absent | 9 | 13 | 4 | .. | .. | .. | .. | .. | |
| No symptoms | |||||||||
| LMCI present | 9 | 22 | 10 | .. | .. | .. | .. | .. | |
| LMCI absent | 43 | 98 | 48 | .. | .. | .. | .. | .. | |
| Total mother–child pairs | 68 | 155 | 68 | .. | .. | .. | .. | .. | |
| Nogueira et al (2018)18 | |||||||||
| CZS | |||||||||
| LMCI present | 0 | 0 | 0 | .. | .. | .. | .. | .. | |
| LMCI absent | 0 | 0 | 0 | .. | .. | .. | .. | .. | |
| OPZRO | |||||||||
| LMCI present | 1 | 2 | 5 | .. | .. | .. | .. | .. | |
| LMCI absent | 0 | 2 | 4 | .. | .. | .. | .. | .. | |
| No symptoms | |||||||||
| LMCI present | 1 | 6 | 3 | .. | .. | .. | .. | .. | |
| LMCI absent | 2 | 16 | 12 | .. | .. | .. | .. | .. | |
| Total mother–child pairs | 4 | 26 | 24 | .. | .. | .. | .. | .. | |
| Spanish cohort (PCR-negative patients reported as having a probable MIP)* | |||||||||
| CZS | |||||||||
| LMCI present | 0 | 1 | 0 | .. | 0 | 0 | 0 | .. | |
| LMCI absent | 2 | 0 | 0 | .. | 0 | 0 | 0 | .. | |
| OPZRO | |||||||||
| LMCI present | 1† | 0 | 0 | .. | 0 | 0 | 0 | .. | |
| LMCI absent | 0 | 1† | 0 | .. | 6 + 1† | 6 | 7 | .. | |
| No symptoms | |||||||||
| LMCI present | 0 | 0 | 0 | .. | 0 | 0 | 0 | .. | |
| LMCI absent | 2 | 6 | 1 | .. | 28 | 48 | 53 | .. | |
| Total mother–child pairs | 5 | 8 | 1 | .. | 35 | 54 | 60 | .. | |
| Hoen et al (2018)17 | |||||||||
| CZS | 13 | 3 | 1 | .. | .. | .. | .. | .. | |
| OPZRO | 11 | 6 | 5 | .. | .. | .. | .. | .. | |
| No symptoms | 165 | 243 | 108 | .. | .. | .. | .. | .. | |
| Total mother–child pairs | 189 | 252 | 114 | .. | .. | .. | .. | .. | |
| Brasil et al (2016; PCR negative patients showed no evidence of MIP)15 | |||||||||
| CZS | 2 | 5 | 0 | .. | 0 | 0 | 0 | .. | |
| OPZRO | 4 + 5† | 29 + 3† | 9 + 1† | .. | 3 | 2 | 1 + 1† | .. | |
| No symptoms | 9 | 34 | 24 | .. | 1 | 33 | 20 | .. | |
| Total mother–child pairs | 20 | 71 | 34 | .. | 4 | 35 | 22 | .. | |
| Conners et al (2018; PCR-negative patients reported as having a suspected MIP)20‡ | |||||||||
| LMCI present | .. | .. | .. | 7 | .. | .. | .. | 11 | |
| LMCI absent | .. | .. | .. | 73 | .. | .. | .. | 196 | |
| Total mother–child pairs | .. | .. | .. | 80 | .. | .. | .. | 207 | |
| Merriam et al (2020; PCR-negative patients reported as having a presumed MIP)21‡ | |||||||||
| CZS | .. | .. | .. | 1 | .. | .. | .. | 0 | |
| OPZRO | .. | .. | .. | 1 + 1† | .. | .. | .. | 6 + 1† | |
| No symptoms | .. | .. | .. | 13 | .. | .. | .. | 47 | |
| Total mother–child pairs | .. | .. | .. | 16 | .. | .. | .. | 54 | |
CZS=congenital Zika syndrome. MIP=maternal infection in pregnancy. LMCI=laboratory markers of congenital infection. OPZRO=other potentially Zika-virus-related outcome.
Fetal losses with undetermined or unreported clinical categorisation.
For proportions of patients with confirmed or suspected infection in each trimester see the appendix (p 4).